查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1735620

全球疫苗注射装置市场规模（按设备、给药途径、最终用户、区域覆盖范围和预测）

Global Vaccine Delivery Devices Market Size By Devices, By Route Of Administration, By End-User, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

疫苗输送装置市场规模及预测

2024 年疫苗输送装置市场规模价值 49.9 亿美元，预计到 2032 年将达到 88.3 亿美元，2026 年至 2032 年的复合年增长率为 8.5%。

  • 疫苗输送装置是专门为疫苗接种而设计的工具和技术。这些装置对于医护人员和个人至关重要，可确保精准剂量、安全输送以及有效预防感染疾病。
  • 疫苗接种装置通常用于医院、诊所和医生办公室等医疗机构的常规免疫计划，包括儿童疫苗接种计划、季节性流感疫苗接种宣传活动和其他预防性健康倡议。
  • 疫苗接种单位在社区健康计画和推广工作中发挥着至关重要的作用，特别是在医疗服务有限的农村和服务不足地区。
  • 无针注射是最新的疫苗注射技术之一，已在大规模疫苗接种计划中得到有效应用，有助于减少针刺伤的机会以及因多次使用一根针而引起的併发症。
  • 此外，其他疫苗输送装置包括喷射注射器、一次性注射器、微针和皮内输送装置，所有这些装置都用于输送灭活脊髓灰质炎疫苗。

疫苗输送装置的全球市场动态

影响疫苗输送设备市场的关键市场动态是：

关键市场驱动因素

  • 强大的研发实力：全球产品供应的不断增长，促进了旨在消除地方病的疫苗接种计划市场的成长。各国政府、医院和製药公司正在推广定期且负担得起的疫苗接种，积极的政府监督也确保每个人都能以最低的成本接种疫苗。
  • 提高医疗保健领域的疫苗接种覆盖率：疫苗接种设备的需求源于扩大疫苗接种覆盖率和覆盖服务不足人群的努力，各国政府、医疗保健组织和非政府组织正在合作提高中低收入国家的免疫接种率。
  • 政府医疗保健支出的增加：疫苗接种设备的需求受到政府主导的努力的推动，这些努力旨在提高疫苗接种覆盖率并向服务不足的人群提供疫苗，这得益于医疗保健组织和非政府组织之间的合作。
  • 技术进步：由于针刺伤、受污染针头导致的感染疾病以及针头消毒不当导致的血源性感染疾病的风险，无针输送装置的需求正在蓬勃发展。主要企业、国际组织和研究机构对新型输送技术的兴趣正在推动市场成长。
  • 例如，2022年1月，辉瑞与Acuitas Therapeutics合作开发了一种专为mRNA疫苗和疗法设计的脂质奈米颗粒递送系统。此次合作旨在利用两家公司的专业知识，提高基于mRNA的疗法和疫苗的递送效率和疗效。

主要挑战

  • 疫苗接种成本高昂：慢性病和感染疾病的日益普及推动了市场的成长。然而，每剂疫苗的高昂成本阻碍了市场的扩张。儘管国际组织已向全球提供了数百万剂疫苗，但由于成本高昂，许多地区仍未接种疫苗。
  • 基础设施挑战：疫苗供应链需要严格的温度控制才能维持效力。在低温运输基础设施薄弱的地区，例如农村和偏远地区，这可能难以实现，这可能会损害疫苗效力并减少对疫苗供应设备的需求。
  • 医疗保健人员能力挑战：缺乏训练有素的医疗保健人员可能会影响疫苗的正确管理，导致管理延迟、管理错误和输送设备处理不当，即使有合适的输送设备，也会影响整体疫苗接种结果。
  • 疫苗供应链中断：供应链中断，包括生产延误、配送瓶颈和物流挑战，可能会影响疫苗配送设备的供应和可及性。自然灾害、地缘政治紧张局势和突发公共卫生事件造成的供应链中断可能会扰乱疫苗接种计划，并限制疫苗配送设备的部署。

主要趋势：

  • 无痛接种：为了提高病患的舒适度和接受度，人们对开发无痛疫苗接种方法的兴趣日益浓厚。微针贴片等技术可以透过侵入性较小、疼痛较小的皮肤穿刺来递送疫苗，可能比传统的针头接种方法更具优势，尤其是在儿童和老年人群体中。
  • 智慧注射器：将数位健康技术融入疫苗传输设备，例如配备感测器和连接功能的智慧注射器，将能够即时监测疫苗接种情况、追踪剂量并确保疫苗接种计画的执行。这些设备将有助于数据收集，增强患者参与度，并支援远端患者监护。
  • 生物分解性和环保材料：随着人们日益重视永续性和环境责任，疫苗输送装置正采用生物分解性和环保材料製造。製造商正在探索传统塑胶的替代品，例如生质塑胶和可堆肥材料，以减少其对环境的影响并推广循环经济原则。

目录

第 1 章全球疫苗输送装置市场简介

  • 市场介绍
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

4. 疫苗输送装置的全球市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

5. 全球疫苗注射装置市场（按设备）

  • 概述
  • 注射器
  • 喷射注射器

6. 全球疫苗注射装置市场（依给药途径划分）

  • 概述
  • 皮内接种
  • 肌肉注射疫苗
  • 皮下接种

7. 全球疫苗注射装置市场（依最终用户划分）

  • 概述
  • 医院和诊所
  • 居家医疗
  • 门诊手术中心

8. 全球疫苗注射装置市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区
    • 拉丁美洲
    • 中东和非洲

9. 全球疫苗输送装置市场的竞争格局

  • 概述
  • 各公司市场排名
  • 主要发展策略

第十章 公司简介

  • 3M
  • Becton Dickinson & Company
  • Gerresheimer AG
  • Bioject Medical Technologies, Inc.（Inovio Pharmaceutical Inc.）
  • SCHOTT AG
  • Valeritas
  • PharmaJet
  • Vaxxas
  • Corium International, Inc

第十一章 附录

  • 相关调查
简介目录
Product Code: 35588

Vaccine Delivery Devices Market Size And Forecast

Vaccine Delivery Devices Market size was valued at USD 4.99 Billion in 2024 and is projected to reach USD 8.83 Billion by 2032, growing at a CAGR of 8.5% from 2026-2032.

  • Vaccine delivery devices are tools and technologies specifically designed for the administration of vaccines. These devices are essential for healthcare professionals and individuals to ensure accurate dosage, safe delivery, and proper immunization against infectious diseases.
  • Vaccine delivery devices are commonly used in healthcare facilities such as hospitals, clinics, and medical offices for routine immunization programs, including childhood vaccination schedules, seasonal flu vaccination campaigns, and other preventive healthcare initiatives.
  • Vaccine delivery devices play a crucial role in community health programs and outreach efforts, particularly in rural or underserved areas where access to healthcare services may be limited.
  • One of the latest vaccine delivery technologies, such as needle-free options, is effectively used in mass immunization programs. It helps to reduce the chances of needle stick injuries and the complications associated with the multiple uses of a single needle.
  • Moreover, other vaccine delivery devices include jet injectors, disposable syringes, microneedles, and intradermal delivery devices. These are all used for the delivery of inactivated poliovirus vaccines.

Global Vaccine Delivery Devices Market Dynamics

The key market dynamics that are shaping the Vaccine Delivery Devices Market include:

Key Market Drivers:

  • Robust Research and Development: The global increase in product supply is facilitating market expansion for vaccination programs aimed at eradicating endemic diseases. Governments, hospitals, and pharmaceutical corporations are promoting routine and affordable vaccinations, with active government surveillance ensuring everyone receives them at minimal cost.
  • Expanded Immunization Coverage in Healthcare Sector: The demand for vaccine delivery devices is driven by efforts to expand immunization coverage and reach underserved populations, with collaboration between governments, healthcare organizations, and NGOs aiming to improve vaccination rates in low- and middle-income countries.
  • Rising Healthcare Expenditure by Government: The demand for vaccine delivery devices is fueled by government-led initiatives to enhance immunization coverage and reach underserved populations, facilitated by collaborations between healthcare organizations and NGOs.
  • Technological Advancements: The demand for needle-free delivery is surging due to the risks of needle stick injuries, infection from contaminated needles, and blood-borne infections from improperly sterilized needles. The market growth is expected to be driven by interest from key players, international organizations, and institutions in novel delivery technologies.
  • For instance, in January 2022, Pfizer Inc. and Acuitas Therapeutics joined forces to develop a lipid nanoparticle delivery system that is specifically designed for mRNA vaccines and therapeutics. This collaboration aims to leverage the expertise of both companies to enhance the delivery efficiency and effectiveness of mRNA-based treatments and vaccines.

Key Challenges:

  • High Costs of Vaccine Dose: The growing incidence of chronic and infectious diseases is driving market growth. However, high costs associated with the per-dose vaccine volume are hampering market expansion. Though international organizations are supplying millions of volume doses around the globe, many parts are yet to receive vaccination due to their high cost.
  • Infrastructure Challenges: The supply chain of vaccines requires strict temperature control to maintain their potency. In regions with inadequate cold chain infrastructure, such as rural or remote areas, this becomes challenging, potentially compromising vaccine effectiveness and decreasing demand for vaccine delivery devices.
  • Healthcare Workforce Capacity Challenges: A shortage of trained healthcare workers is hindering the proper administration of vaccines, leading to delays, dosage errors, and improper handling of delivery devices, affecting overall immunization outcomes, even with adequate delivery devices available.
  • Disruptions in the Vaccine Supply Chain: Supply chain disruption such as manufacturing delays, distribution bottlenecks, and logistics challenges, is likely to impact the availability and accessibility of vaccine delivery devices. Supply chain disruptions, whether due to natural disasters, geopolitical tensions, or public health emergencies, may disrupt immunization programs and limit the deployment of vaccine delivery devices.

Key Trends:

  • Painless Administration: There is growing interest in developing painless vaccine delivery methods to enhance patient comfort and acceptance. Technologies such as microneedle patches, which deliver vaccines through painless, minimally invasive skin punctures, offer potential advantages over traditional needle-based injections, particularly for pediatric and geriatric populations.
  • Smart Injection Devices: Integration of digital health technologies into vaccine delivery devices, such as smart injection devices equipped with sensors and connectivity features, allows for real-time monitoring of vaccination administration, dosage tracking, and adherence to vaccination schedules. These devices facilitate data collection, enhance patient engagement, and support remote patient monitoring.
  • Biodegradable and Eco-Friendly Materials: Increasing emphasis on sustainability and environmental responsibility drives the adoption of biodegradable and eco-friendly materials in vaccine delivery devices. Manufacturers are exploring alternatives to conventional plastics, such as bioplastics and compostable materials, to reduce environmental impact and promote circular economy principles.

Global Vaccine Delivery Devices Market Regional Analysis

Here is a more detailed regional analysis of the global Vaccine Delivery Devices Market:

North America:

  • North America has established regulatory frameworks for healthcare products, including vaccine delivery devices, overseen by agencies like the FDA and Health Canada. These standards ensure safety, efficacy, and quality, boosting consumer confidence and market growth.
  • The region is at the forefront of technological innovation in healthcare, including vaccine delivery devices. Advancements such as needle-free injectors, auto-disable syringes, and smart injection devices improve vaccine administration, enhance patient comfort, and optimize immunization outcomes.
  • North America is home to several key market players, including pharmaceutical companies, medical device manufacturers, and healthcare technology firms. These companies drive innovation, research, and development in vaccine delivery devices, introducing new products and technologies to the market.

Europe:

  • Europe places a strong emphasis on healthcare quality and safety, driving the adoption of advanced healthcare technologies and best practices. Vaccine delivery devices must meet high standards of safety, reliability, and performance to ensure patient well-being and public health outcomes.
  • European governments provide support for vaccination programs through funding, policy development, and public health campaigns. National vaccination schedules, recommendations, and incentives encourage vaccination uptake and drive demand for vaccine delivery devices across healthcare settings.
  • European countries continue to invest in healthcare infrastructure, research and development, and innovation to improve healthcare delivery and patient outcomes. Investments in vaccination programs, including the procurement of vaccine delivery devices, contribute to market growth and innovation in the region.

Asia Pacific:

  • Asia Pacific is home to some of the world's most populous countries, including China and India. The sheer size of the population creates a substantial demand for vaccines and vaccine delivery devices to address healthcare needs.
  • Economic growth in many countries across the Asia Pacific region has led to increased healthcare spending. Governments and private sectors are investing more in healthcare infrastructure, including vaccination programs and the procurement of vaccine delivery devices.
  • There is a growing awareness among individuals and communities in the Asia Pacific about the importance of preventive healthcare measures, including vaccination. Public health campaigns, educational initiatives, and advocacy efforts contribute to increased vaccination uptake and demand for vaccine-delivery devices.
  • Emerging economies in Asia Pacific, such as China, India, Indonesia, and Vietnam, offer significant growth opportunities due to their large populations and increasing investments in healthcare infrastructure. These countries are witnessing rapid urbanization, economic development, and healthcare reforms, driving demand for healthcare products and services, including vaccine delivery devices.

Global Vaccine Delivery Devices Market: Segmentation Analysis

The Global Medical Sensors Market is Segmented on the basis of Devices, Route Of Administration, End-User, And Geography.

Vaccine Delivery Devices Market, By Devices

  • Syringes
  • Jet Injectors

Based on Devices, The market is segmented into Syringes and Jet Injectors. Among these, syringes are expected to dominate the market as they provide flexibility in administering various vaccinations, including liquid and lyophilized vaccines (which are freeze-dried and need to be reconstituted before use). Syringes can be used in various immunization situations. However, the jet injectors segment of the Vaccine Delivery Devices Market is expanding at the quickest rate.

Vaccine Delivery Devices Market, By Route Of Administration

  • Intradermal Vaccination
  • Intramuscular Vaccination
  • Subcutaneous Vaccination

Based on Route Of Administration, The market is segmented into Intradermal, Intramuscular, and Subcutaneous. The largest market segment is intradermal, which enhances immunogenicity by interacting directly with skin-derived immune cells. Intramuscular, the most rapidly growing segment, is recommended for administering a wide range of vaccinations, booster shots, and routine immunizations to individuals of all ages due to its versatility.

Vaccine Delivery Devices Market, By End-User

  • Hospitals & Clinics
  • Home Care Settings
  • Ambulatory Surgery Centers

Based on End-User, The market is segmented into Hospitals & clinics, Home Care Settings, and Ambulatory Surgery Centers. Hospitals typically account for the majority share in the end-user segment of the Vaccine Delivery Devices Market. Hospitals often serve as centralized hubs for vaccination services, providing a wide range of vaccines to patients across various age groups and medical conditions. Academic medical centers and research hospitals play a key role in vaccine research, clinical trials, and medical education. They utilize vaccine delivery devices for research purposes, vaccine trials, and training healthcare professionals.

Key Players

The "Global Vaccine Delivery Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are 3M, Becton Dickinson & Company, Gerresheimer AG, Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.), SCHOTT AG, Valeritas, PharmaJet, Vaxxas, and Corium International, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

  • Vaccine Delivery Devices Market, Recent Developments
  • In March 2022, The National Institute of Allergy and Infectious Diseases (NIAID) initiated a clinical trial to evaluate three experimental HIV vaccines. These vaccines are developed using a messenger RNA (mRNA) platform, which has been previously used in multiple Covid-19 vaccines that have been approved.
  • In April 2023, the FDA approved CSL's immunoglobulin pre-filled syringe, Hizentra, for use in treating patients with chronic inflammatory demyelinating conditions. Primary Immunodeficiency (PI) and Polyneuropathy (CIDP). The injection offers convenient drug delivery and is ready for use.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL VACCINE DELIVERY DEVICES MARKET

  • 1.1 Introduction of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL VACCINE DELIVERY DEVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY DEVICES

  • 5.1 Overview
  • 5.2 Syringes
  • 5.3 Jet Injectors

6 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION

  • 6.1 Overview
  • 6.2 Intradermal Vaccination
  • 6.3 Intramuscular Vaccination
  • 6.4 Subcutaneous Vaccination

7 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Hospitals & Clinics
  • 7.3 Home Care Settings
  • 7.4 Ambulatory Surgery Centers

8 GLOBAL VACCINE DELIVERY DEVICES MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL VACCINE DELIVERY DEVICES MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 3M
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Becton Dickinson & Company
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Gerresheimer AG
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.)
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 SCHOTT AG
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Valeritas
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 PharmaJet
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Vaxxas
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Corium International, Inc
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments

11 Appendix

  • 11.1 Related Research